Safety and Pharmacokinetics of Zanubrutinib (BGB-3111) in Healthy Subjects and Those With Impaired Liver Function
Clinical trial NCT03465059 · COMPLETED
Trial details
- NCT number
- NCT03465059
- Sponsor
- BeiGene
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-05-30
- Primary completion
- 2018-10-19
- Enrollment
- 29
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.